234 related articles for article (PubMed ID: 26981638)
1. Modification of the hTERT promoter by heat shock elements enhances the efficiency and specificity of cancer targeted gene therapy.
Wang X; Zhou P; Sun X; Wei G; Zhang L; Wang H; Yao J; Jia P; Zheng J
Int J Hyperthermia; 2016 May; 32(3):244-53. PubMed ID: 26981638
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of a dual-specific lentiviral vector carrying the Escherichia coli purine nucleoside phosphorylase gene.
Wang X; Sun L; Sun X; Yu J; Wang K; Wu Y; Gao Q; Zheng J
Int J Oncol; 2017 May; 50(5):1612-1622. PubMed ID: 28393254
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted efficiency of shRNA vector harboring chimera hTERT/U6 promoter.
Zhang P; Chen Y; Jiang X; Tu Z; Zou L
Oncol Rep; 2010 May; 23(5):1309-16. PubMed ID: 20372845
[TBL] [Abstract][Full Text] [Related]
4. Use of rhenium-188 for in vivo imaging and treatment of human cervical cancer cells transfected with lentivirus expressing sodium iodide symporter.
Zhang M; Shi S; Guo R; Miao Y; Li B
Oncol Rep; 2016 Oct; 36(4):2289-97. PubMed ID: 27573304
[TBL] [Abstract][Full Text] [Related]
5. Suppression of cancer growth in mice by adeno-associated virus vector-mediated IFN-beta expression driven by hTERT promoter.
He LF; Wang YG; Xiao T; Zhang KJ; Li GC; Gu JF; Chu L; Tang WH; Tan WS; Liu XY
Cancer Lett; 2009 Dec; 286(2):196-205. PubMed ID: 19564073
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
[TBL] [Abstract][Full Text] [Related]
7. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
8. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
10. Enhanced suicide gene therapy by chimeric tumor-specific promoter based on HSF1 transcriptional regulation.
Wang J; Yao M; Zhang Z; Gu J; Zhang Y; Li B; Sun L; Liu X
FEBS Lett; 2003 Jul; 546(2-3):315-20. PubMed ID: 12832060
[TBL] [Abstract][Full Text] [Related]
11. [Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells].
Wang YP; Tang XJ; Chen XH; Che GW; Zhu DX; Sun ZL; Zhou QH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):497-501. PubMed ID: 16909587
[TBL] [Abstract][Full Text] [Related]
12. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle-specific changes in hTERT promoter activity in normal and cancerous cells in adenoviral gene therapy: a promising implication of telomerase-dependent targeted cancer gene therapy.
Murofushi Y; Nagano S; Kamizono J; Takahashi T; Fujiwara H; Komiya S; Matsuishi T; Kosai K
Int J Oncol; 2006 Sep; 29(3):681-8. PubMed ID: 16865285
[TBL] [Abstract][Full Text] [Related]
14. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
[TBL] [Abstract][Full Text] [Related]
16. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
17. Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer.
Song JS
Biosci Biotechnol Biochem; 2004 Aug; 68(8):1634-9. PubMed ID: 15322345
[TBL] [Abstract][Full Text] [Related]
18. [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy].
Zhang Y; Ma H; Liu SL; Liu YX; Zheng DX
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):475-9. PubMed ID: 18642790
[TBL] [Abstract][Full Text] [Related]
19. In vitro effect of focused ultrasound or thermal stress on HSP70 expression and cell viability in three tumor cell lines.
Hundt W; O'Connell-Rodwell CE; Bednarski MD; Steinbach S; Guccione S
Acad Radiol; 2007 Jul; 14(7):859-70. PubMed ID: 17574136
[TBL] [Abstract][Full Text] [Related]
20. MR molecular imaging of tumors based on an optimal hTERT promoter tyrosinase expression system.
Li C; Hu CJ; Tang B; Yong X; Luo G; Wu YY; Wang SM; Yu ST; Yang SM
Oncotarget; 2016 Jul; 7(27):42474-42484. PubMed ID: 27283901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
